🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/11/2002 | 53,32 | 54,29 | 52,91 | 53,97 | +2,15% | 2,59% | 6.693.157 |
| 15/11/2002 | 51,59 | 52,85 | 51,55 | 52,83 | +2,65% | 2,53% | 8.281.610 |
| 14/11/2002 | 50,39 | 51,70 | 49,92 | 51,47 | +2,16% | 3,52% | 8.597.373 |
| 13/11/2002 | 51,62 | 52,47 | 49,43 | 50,38 | -3,68% | 5,90% | 13.138.986 |
| 12/11/2002 | 52,59 | 53,04 | 51,92 | 52,31 | -0,38% | 2,14% | 6.116.966 |
| 11/11/2002 | 53,34 | 53,50 | 52,17 | 52,51 | -1,59% | 2,50% | 5.238.323 |
| 08/11/2002 | 52,88 | 53,87 | 52,67 | 53,36 | +0,90% | 2,27% | 7.123.570 |
| 07/11/2002 | 52,75 | 53,42 | 52,73 | 52,88 | -1,04% | 1,30% | 7.455.472 |
| 06/11/2002 | 51,73 | 54,01 | 51,73 | 53,44 | +3,32% | 4,41% | 15.335.594 |
| 05/11/2002 | 51,23 | 51,90 | 50,57 | 51,72 | +0,97% | 2,59% | 7.923.299 |
| 04/11/2002 | 51,81 | 52,58 | 51,10 | 51,22 | -0,70% | 2,85% | 7.671.360 |
| 01/11/2002 | 51,05 | 52,19 | 50,69 | 51,58 | -0,33% | 2,95% | 7.383.370 |
| 31/10/2002 | 51,76 | 52,39 | 51,24 | 51,76 | +0,00% | 2,21% | 6.750.692 |
| 30/10/2002 | 51,15 | 51,99 | 50,70 | 51,76 | +1,48% | 2,54% | 5.663.497 |
| 29/10/2002 | 51,19 | 52,30 | 50,11 | 51,00 | -1,44% | 4,27% | 7.656.688 |
| 28/10/2002 | 51,91 | 52,71 | 51,36 | 51,75 | +2,49% | 2,61% | 12.329.930 |
| 25/10/2002 | 48,18 | 50,55 | 47,82 | 50,49 | +4,79% | 5,66% | 6.544.236 |
| 24/10/2002 | 49,11 | 49,57 | 47,76 | 48,18 | -1,69% | 3,69% | 6.012.690 |
| 23/10/2002 | 47,69 | 49,06 | 47,43 | 49,01 | +1,40% | 3,40% | 7.088.148 |
| 22/10/2002 | 48,09 | 48,57 | 47,49 | 48,33 | -0,98% | 2,24% | 6.047.798 |
| 21/10/2002 | 47,09 | 49,11 | 47,00 | 48,81 | +0,24% | 4,48% | 8.224.494 |
| 18/10/2002 | 48,43 | 48,85 | 46,85 | 48,69 | +0,55% | 4,12% | 11.185.828 |
| 17/10/2002 | 48,86 | 48,89 | 47,83 | 48,43 | +1,70% | 2,17% | 6.491.312 |
| 16/10/2002 | 48,62 | 49,24 | 47,15 | 47,61 | -1,93% | 4,30% | 7.044.761 |
| 15/10/2002 | 48,28 | 48,68 | 47,81 | 48,55 | +2,58% | 1,80% | 9.736.339 |
| 14/10/2002 | 45,14 | 47,99 | 45,14 | 47,33 | +4,86% | 6,30% | 9.880.125 |
| 11/10/2002 | 43,90 | 45,52 | 43,64 | 45,13 | +2,80% | 4,30% | 5.636.982 |
| 10/10/2002 | 43,54 | 44,13 | 42,40 | 43,90 | +0,83% | 3,99% | 9.122.840 |
| 09/10/2002 | 42,46 | 44,79 | 41,36 | 43,54 | -0,80% | 8,07% | 12.833.808 |
| 08/10/2002 | 42,94 | 44,66 | 42,59 | 43,89 | +4,24% | 4,82% | 7.907.789 |